Edward Chesney

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Therapeutic advances in psychopharmacology

Addiction (Abingdon, England)

Cannabis and cannabinoid research

King's College London

King's College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King's College London Aug 01 2016

United Kingdom

Academic Clinical Fellow :: Department of Psychosis Studies

South London and Maudsley NHS Foundation Trust Aug 01 2016

United Kingdom

Psychiatrist :: Psychiatry

Royal London Hospital Aug 01 2015 - Aug 01 2016

United Kingdom

Foundation Year 2 Doctor :: Renal Medicine/Sexual Health/Paediatric A&E

Princess Alexandra Hospital NHS Trust Jul 27 2014 - Aug 03 2015

United Kingdom

Foundation Doctor :: Old Age Psychiatry/General Surgery/General Medicine

Education History

King's College London Feb 01 2020

United Kingdom

PHD :: Psychosis Studies

Publications

Matthew Atkins, David M Taylor, Ana Catalan, Neville Desouza, Edward Chesney, Thomas J Reilly, Irina Baburina, Mary Rose Hilaire, Luiz Dratcu, Robert Harland, Salvatore J Salamone, Philip K McGuire
Point of care assay for blood aripiprazole concentrations: development, validation and utility. The British journal of psychiatry : the journal of mental science (2023)
Edward Chesney, Will Lawn, Philip McGuire
Assessing Cannabis Use in People with Psychosis. Cannabis and cannabinoid research (2023)
Dominic Oliver, Amir Englund, Edward Chesney, Lucy A Chester, Jack Wilson, Simina Sovi, Stina Wigroth, John Hodsoll, Sir John Strang, Robin M Murray, Tom P Freeman, Paolo Fusar-Poli, Philip K McGuire
Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study. Addiction (Abingdon, England) (2023)
Amir Englund, Dominic Oliver, Edward Chesney, Lucy Chester, Jack Wilson, Simina Sovi, Andrea De Micheli, John Hodsoll, Paolo Fusar-Poli, John Strang, Robin M Murray, Tom P Freeman, Philip K McGuire
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2022)
Edward Chesney, Doga Lamper, Millie Lloyd, Dominic Oliver, Emily Hird, Philip McGuire
Acceptability of cannabidiol in patients with psychosis. Therapeutic advances in psychopharmacology 12 (2022)
Edward Chesney, Dominic Oliver, Philip McGuire
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis. Psychopharmacology (2021)
Edward Chesney, Philip McGuire, Tom P Freeman, John Strang, Amir Englund
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products. Therapeutic advances in psychopharmacology 10 (2020)
Lucy A Chester, Edward Chesney, Dominic Oliver, Jack Wilson, Amir Englund
How experimental cannabinoid studies will inform the standardized THC unit. Addiction (Abingdon, England) 115 (7) (2020)
Edward Chesney, Dominic Oliver, Alastair Green, Simina Sovi, Jack Wilson, Amir Englund, Tom P Freeman, Philip McGuire
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (11) (2020)

Edward Chesney.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Edward Chesney